Clinical Study Demonstrates Viability of NeuraLight's Digital Biomarker Platform to Evaluate and Monitor Parkinson's Disease Progression webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
NeuraLight has launched from stealth with $5.5 million in seed funding to apply AI to advance drug development for neurological disorders. The company was co-founded by Micha Breakstone, the co-founder and former president of Chorus.ai, which sold to ZoomInfo for $575 million earlier this year. Breakstone now leads NeuraLight as the company’s CEO alongside co-founder […]